Use of vaccinia virus expression vectors to investigate antigen processing and presentation.
Wherry
E J
EJ
Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA.
Rajagopal
D
D
Eisenlohr
L C
LC
D000818:Animals; D017951:Antigen Presentation; D018929:Cell Culture Techniques / Q000379:methods; D002460:Cell Line; D002522:Chlorocebus aethiops; D003602:Cytotoxicity, Immunologic; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005822:Genetic Vectors; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans; D051379:Mice; D008815:Mice, Inbred Strains; D011995:Recombination, Genetic; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D013937:Thymidine Kinase / Q000235:genetics; D014162:Transfection / Q000379:methods*; D014407:Tumor Cells, Cultured; D014616:Vaccinia virus / Q000235:genetics* / Q000502:physiology; D014773:Virology / Q000379:methods; D014779:Virus Replication
D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D013937:Thymidine Kinase